The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ALLOGENE THERAPEUTICS INC COM 019770106 386 15,000 SH   SOLE   15,000 0 0
AMICUS THERAPEUTICS INC COM 03152W109 96 10,000 SH   SOLE   10,000 0 0
ARCUS BIOSCIENCES INC COM 03969F109 593 17,000 SH   SOLE   17,000 0 0
BIOMARIN PHARMACEUTICAL INC COM 09061G101 850 11,000 SH   SOLE   11,000 0 0
FATE THERAPEUTICS INC COM 31189P102 711 12,000 SH   SOLE   12,000 0 0
HORIZON THERAPEUTICS PUB L SHS G46188101 657 6,000 SH   SOLE   6,000 0 0
IMMATICS N.V SHS N44445109 130 10,000 SH   SOLE   10,000 0 0
JOHNSON & JOHNSON COM 478160104 808 5,000 SH   SOLE   5,000 0 0
MEDTRONIC PLC SHS G5960L103 376 3,000 SH   SOLE   3,000 0 0
PFIZER INC COM 717081103 1,290 30,000 SH   SOLE   30,000 0 0
PROQR THRAPEUTICS N V SHS EURO N71542109 335 40,000 SH   SOLE   40,000 0 0
TELADOC HEALTH INC COM 87918A105 888 7,000 SH   SOLE   7,000 0 0
THERMO FISHER SCIENTIFIC INC COM 883556102 1,143 2,000 SH   SOLE   2,000 0 0